This Article Full Text Full Text (PDF) All Versions of this Article: 34/10/2508    most recent 01.STR.0000089922.94684.13v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilby, M. J. Articles by Kirkpatrick, P. J. Search for Related Content PubMed PubMed Citation Articles by Wilby, M. J. Articles by Kirkpatrick, P. J. Related Collections Acute Cerebral Hemorrhage Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Intracerebral Hemorrhage Aneurysm, AVM, hematoma

(Stroke. 2003;34:2508.)
© 2003 American Heart Association, Inc.

Original Contributions

Cost-Effective Outcome for Treating Poor-Grade Subarachnoid Hemorrhage

Martin J. Wilby, PhD; Melanie Sharp, BS, MB; Peter C. Whitfield, FRCS(SN); Peter J. Hutchinson, FRCS(SN); David K. Menon, FMedSci Peter J. Kirkpatrick, FRCS(SN)

From the Academic Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge (M.J., M.S., P.J.H., D.K.M., P.J.K.); Aberdeen Royal Infirmary, Grampian University Hospitals Trust, Aberdeen (M.S., P.C.W.); and South West Neurosurgical Unit, Derriford Hospital, Plymouth (P.C.W.), UK.

Reprint requests to Peter J. Kirkpatrick, FRCS(SN), Box 167, Academic Department of Neurosurgery, Addenbrooke’s Hospital, Hills Rd, Cambridge CB2 2QQ UK. E-mail pjk21{at}medschl.cam.ac.uk

Background and Purpose— The goal of this study was to prospectively assess outcome and cost for poor-grade subarachnoid hemorrhage patients presenting to a regional neurosurgical center (Addenbrooke’s Hospital, Cambridge, UK) between 1994 and 2001. Outcome measures were clinical outcome at 6 months, number needed to treat (NNT) for favorable outcomes, and cost analysis.

Methods— Poor-grade patients (World Federation of Neurological Surgeons grades 4 and 5) were transferred to the neurocritical care unit after intubation and ventilation. After resuscitation and drainage of ventricular cerebrospinal fluid for 24 hours, sedation was stopped, and patients were assessed clinically. Patients with a Glasgow Motor Score (GMS) 4 underwent angiography and surgical treatment of culprit aneurysms. Patients with a subsequent GMS of 6 were not deemed poor grade and were discounted from the study.

Results— We deemed 166 ventilated patients genuinely poor grade (mean age, 53.4 years; 94 women [56.6%]). Of these, 88 patients (4<GMS<6; 53%) progressed to angiography and possible definitive treatment. Seventy-five patients had an identifiable aneurysm, but only 64 survived for treatment. Operative mortality was 31.3%, and of the 44 survivors, 22 (34.4% of operated patients) achieved a favorable outcome. Favorable outcomes were more frequently seen in women than men (21.3% versus 6.9%) but were unrelated to patient age. The NNT for 1 favorable outcome was 7 (male NNT, 15; female NNT, 5) at a cost of £84 336 per favorable outcome (female, £60 240; male, £180 720).

Conclusions— Poor-grade aneurysmal subarachnoid hemorrhage is associated with a high mortality but a significant subset of patients can achieve favorable outcomes.

Key Words: cost-effective analysis • outcome • subarachnoid hemorrhage

This article has been cited by other articles:

				R. Luengo-Fernandez, A. M. Gray, and P. M. Rothwell Costs of Stroke Using Patient-Level Data: A Critical Review of the Literature Stroke, February 1, 2009; 40(2): e18 - e23. [Abstract] [Full Text] [PDF]

				J. van Loon, G. Wilms, P. J. Kirkpatrick, and M. Wilby Cost-Effective Outcome for Treating Poor-Grade SAH * Response Stroke, April 1, 2004; 35(4): e83 - e84. [Full Text] [PDF]